Stockscreener 앱 받기
9.69
0.31%
0.03
시간 외 거래:
9.69
Replimune Group Inc 주식(REPL)의 최신 뉴스
Is Replimune Group Inc. stock overvalued by current metricsEarnings Recap Report & AI Forecasted Entry and Exit Points - Улправда
Faruqi & Faruqi Reminds Replimune Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025REPL - TMX Newsfile
Replimune to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Biotech pioneering oncolytic immunotherapies to speak at J.P. Morgan - Stock Titan
Replimune Shares Face Mounting Headwinds - AD HOC NEWS
Insiders At Replimune Group Sold US$766k In Stock, Alluding To Potential Weakness - simplywall.st
Replimune Group, Inc. (NASDAQ:REPL) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Replimune Group earns relative strength rating upgrade; hits key benchmark - MSN
What analysts say about Replimune Group Inc stockVolume Spike Alerts & Free Trading Signals to Sharpen Your Edge - earlytimes.in
Replimune Group, Inc. $REPL Holdings Trimmed by Braidwell LP - MarketBeat
Replimune Group (NASDAQ:REPL) Director Kapil Dhingra Sells 3,169 Shares - MarketBeat
Replimune Group, Inc. $REPL Shares Sold by Redmile Group LLC - MarketBeat
Replimune Group Director Kapil Dhingra Sells All Shares - TradingView — Track All Markets
[Form 4] Replimune Group, Inc. Insider Trading Activity - Stock Titan
Replimune Group, Inc. $REPL Shares Sold by Marshall Wace LLP - MarketBeat
Nan Fung Group Holdings Ltd Lowers Stock Position in Replimune Group, Inc. $REPL - MarketBeat
Replimune Group (REPL) Price Target Increased by 10.52% to 12.82 - Nasdaq
Insider Selling: Replimune Group (NASDAQ:REPL) CEO Sells 10,000 Shares of Stock - MarketBeat
Replimune Stock Presents a Complex Investment Narrative - AD HOC NEWS
Saturn V Capital Management LP Takes $1.20 Million Position in Replimune Group, Inc. $REPL - MarketBeat
Replimune Group CEO Sushil Patel Sells 10,000 Shares - TradingView
CEO Patel Sells 10,000 ($111.3K) Of Replimune Group Inc [REPL] - TradingView
Levi & Korsinsky Notifies Replimune Group, Inc. (REPL) Investors - The National Law Review
Levi & Korsinsky Helps Retail Investors SueWallSt Over Alleged Fraud by Replimune Group, Inc. - The National Law Review
Will Replimune Group Inc. stock reach all time highs in 2025Oil Prices & Risk Managed Investment Strategies - BỘ NỘI VỤ
How Replimune Group Inc. stock trades during market volatility2025 Geopolitical Influence & Short-Term High Return Ideas - BỘ NỘI VỤ
Replimune (REPL) Faces Securities Class Action Following Stock's Collapse Amid FDA's Rejection of Melanoma DrugHagens Berman (PR Newswire) - Aktiellt
What Is Driving Replimune Stock’s 98% Surge Today? - MSN
Can One97 Communications Limited Deliver Consistent Free Cash FlowsVolume Spike Alerts & Swing Trade Smarter With Data Insights - earlytimes.in
Replimune Group Inc. stock volume spike explainedWeekly Stock Analysis & Short-Term Trading Alerts - newser.com
How Replimune Group Inc. stock reacts to global recession fearsMarket Trend Review & Smart Investment Allocation Insights - newser.com
Replimune Group (NASDAQ:REPL) Insider Sells $47,392.80 in Stock - MarketBeat
Will Replimune Group Inc. stock deliver shareholder valueQuarterly Trade Summary & Weekly Watchlist for Consistent Profits - newser.com
Using AI based signals to follow Replimune Group Inc.Bond Market & Long Hold Capital Preservation Tips - newser.com
Trend analysis for Replimune Group Inc. this weekWeekly Market Outlook & Low Volatility Stock Suggestions - newser.com
Replimune Group Executives Sell Shares for Tax Obligations - TradingView
Why Replimune Group Inc. stock is a must watch in 2025July 2025 Levels & Weekly High Momentum Picks - newser.com
Smart tools for monitoring Replimune Group Inc.’s price actionWeekly Trade Summary & Accurate Entry and Exit Point Alerts - newser.com
Replimune Group Inc. (REPL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Will Replimune Group Inc. stock benefit from AI adoption2025 Top Decliners & Technical Entry and Exit Alerts - newser.com
How to use Fibonacci retracement on Replimune Group Inc.2025 Top Gainers & Risk Managed Trade Strategies - newser.com
Will Replimune Group Inc. stock deliver consistent dividendsEarnings Beat & Low Drawdown Investment Strategies - newser.com
How to build a custom watchlist for Replimune Group Inc.Weekly Investment Report & Weekly Watchlist of Top Performers - newser.com
Replimune Group (REPL) Stock Analysis Report | Financials & Insights - Benzinga
How Replimune Group Inc. stock compares to growth peersTrade Entry Report & Safe Entry Trade Signal Reports - newser.com
0.31%
0.33%
자본화:
|
볼륨(24시간):